This site is intended for healthcare professionals only
LoginRegister
AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer TrialAstraZeneca-Ionis Pharma Wainzua approved in EU for hereditary transthyretin-mediated amyloidosis in...
CDSCO Panel Rejects Hetero Labs Plea for Lenacapavir Approval Without Local TrialsHetero Healthcare Gets CDSCO Panel Nod To Conduct Phase III clinical trial of Tioconazole vaginal...
Mylan Pharmaceutical Gets CDSCO Panel Nod To study SelatogrelMylan Pharmaceutical Gets CDSCO Panel Nod To study Selatogrel
HRV Pharma, SMS LifeSciences Partner to Scale Orphan and Specialty APIsBlacklisted Drugs Used, 33%-47% Essential Medicines Unavailable, Delhi Still Using 1994 Drug...
Alkem Foundation, IIT Bombay collaborate to set up advanced research centre for immunotherapeutics, regenerative medicinesZydus Lifesciences to acquire Amplitude Surgical for Rs 2,447 crore
Gland Pharma Pashamylaram facility receives GMP compliance certificate from Danish Medicines AgencyGland Pharma ropes in Wriddhee Maitra as Vice-President (Human Resources)
Syngene International, Bristol Myers Squibb Extend Strategic Collaboration Through 2035Syngene buys its first manufacturing facility in US for USD36.5 million
Alkem Gets EU GMP Compliance Certificate for Daman Facility from Malta AuthorityAlkem Labs appoints Shirish Purushotham Ambulgekar at senior management position
USV Acquires 79% Stake in Wellbeing Nutrition, Values D2C Startup at Rs 1,583 CrCCI approves acquisition of pharma solution segment, product lines of Nourish segment of IFF by...
CDSCO Orders Strict Regulation of IVF, ART Medical Devices, Bars Unlicensed SaleCDSCO Introduces Online Export NOC System on SUGAM Portal
CDSCO Panel Rejects Hetero Labs Plea for Lenacapavir Approval Without Local TrialsHetero Labs Gets CDSCO Panel Nod To study Semaglutide Injection for Type 2 Diabetes Mellitus
Indoco Remedies CRO AnaCipher gets one Form 483 from USFDAIndoco Remedies CRO AnaCipher gets one Form 483 from USFDA
X